Direct injection of adenoviral vectors into ventricular myocardium in vivo produces local transfection of cells including cardiomyocytes. The use of vectors coexpressing GFP with the gene of interest allows subsequent identification of transfected myocytes isolated from the heart some days later, and examination of their function in cell bath experiments. We have injected vectors for antisense to phospholamban, or a control virus for expression of GFP only, into adult rat heart in vivo and then removed the heart and isolated ventricular myocytes 7 days later. Brief immobilization of the ventricle during and after injection using a haemoclip increased the number of transfected rod-shaped, viable myocytes from 1.770.8% (n ¼ 8) to 5.670.8% (n ¼ 9). This was further increased to 13.271.1% (n ¼ 8) by the application of ultrasound pulses to the site before and after injection. Phospholamban antisense increased contraction amplitude and accelerated myocyte relengthening or decline of the Ca 
Introduction
Gene transfer to cardiomyocytes within the heart has been achieved by both focal and global methods. [1] [2] [3] While global gene transfer, for example by coronary perfusion, is desirable for uniform modulation of myocyte function, focal methods such as direct injection offer other advantages. In experiments with obvious clinical relevance, direct injection of myocytes has modified pacemaker activity, 4 and has been used to produce new pacemaker areas separate from the nodal tissue. 5 For experimental cardiology, the production of a small to moderate number of transfected myocytes within a largely nontransfected heart has several possible uses. The use of bicistronic adenoviral vectors expressing both the gene of interest and green fluorescent protein (GFP) allows the subsequent identification of transfected cells. 6, 7 When myocytes are isolated from treated hearts, the function of transfected and nontransfected cells from the same ventricle can be directly compared. This in itself is advantageous because it removes intersample variability and minimizes animal use, but it also has two further advantages. First, that the effects of gene modulation can be studied in freshly isolated myocytes.
It is well established that adult myocytes dedifferentiate in culture, and that changes in membrane structure and excitation-contraction coupling can be seen within 24 h. 8 Adenoviral transfection in vitro requires culture of myocytes for 24-48 h, and there is therefore the possibility that culture-induced changes in function may complicate interpretation of results. Overexpression of proteins can be achieved within this period, but downregulation using antisense or siRNA additionally depends on the turnover of the protein and can therefore require a longer time.
A second use of gene transfer to small numbers of myocytes is that the effects of an intervention applied to the heart in vivo may be compared between transfected and nontransfected myocytes without altering global heart function, and thus inducing reflex alterations in homeostasis. For example, gene transfer of targets that enhance function of the failing heart may also reduce sympathetic drive through baroreceptor feedback. It will then be difficult to determine whether cellular alterations in adrenoceptor response are a primary or secondary result of gene transfer.
In the present study, we describe several methods for increasing myocyte transfection with adenovirus so that 1-10% of myocytes subsequently isolated from the adult rat heart may be identified as possessing the gene of interest, and compare for the first time the functional effect of myocytes transfected in vivo with those cultured in vitro. We have used a vector containing an antisense message for phospholamban, to reduce the amount of this inhibitory protein and increase the activity of the sarcoplasmic reticulum (SR) Ca 2+ -ATPase. In previous studies we have shown that this vector increases contraction amplitude and speed relaxation of myocytes isolated from rat, rabbit and human hearts. 3, 9, 10 
Methods

Adenoviral vectors
Ad.PlbAs.GFP contains the complete phospholamban antisense sequence subcloned into the adenoviral shuttle vector, which uses the CMV Long Terminal Repeat as a promoter. The shuttle vector used has a concomitant GFP under the control of a separate CMV promoter as described. 11 Control virus (Ad.GFP) contained the CMV-GFP sequence only. Both vectors were the kind gift of Drs del Monte and Hajjar, Cardiovascular Research Center, Harvard Medical School, Massachusetts General Hospital, Boston.
Injection of adenovirus
Male Sprague-Dawley rats (200-300 g) were anaesthetized, a left anterior thoracotomy performed at the 3rd (ordinary direct injection, o-DI) or 4th (modified direct injection) intercostal space and the heart exposed. Using a 27-gauge needle bent approximately 3 mm from the tip, 100 ml PBS solution containing 10 9 -10 10 active adenoviral particles was injected into the apical myocardium of the left ventricle. For direct injection with immobilization (i-DI), a small haemoclip was placed across the ventricles approximately half way between apex and base. The injection was performed as for o-DI and the haemoclip kept in place for 10 s. For the third method, an ultrasound probe suitable for use with rat heart (Sonitron 1000, Rich-Mar, Inola, OK, USA) was placed onto the ventricle at the site of injection and run at 1 MHz, 1.5 W/ cm 2 , 100% duty cycle for 5 min before and 5 min after injection. The chest was closed and the animal kept under a suitable analgesic and antibiotic regime. After 1 week, the rat was killed and the heart removed for myocyte isolation.
Isolation of ventricular myocytes
Hearts were retrogradely perfused with a low calcium (LC) solution (NaCl 120, KCl 5.4, MgSO 4 5, pyruvate 5, glucose 20, taurine 20, HEPES 10 and nitrilotriacetic acid (NTA) 5 (mmol/l), pH 6.95, preoxygenated with 100% O 2 ) for 5 min. This was followed by 10 min recirculation perfusion with 1 mg/ml collagenase (Worthington, Lorne Laboratories, Twyford, UK) suspended in the LC solution without NTA, and with 200 mM Ca 2+ (ES solution, pH 7.4). The left ventricle was divided half way between apex and base and the lower half (containing the injection site) was chopped and shaken under 100% O 2 in collagenase for a further 2 Â 10 min. The myocytes were washed in ES solution by two low-speed centrifugations, and resuspended in the same solution. The number of green fluorescent myocytes was counted on a Nikon TE200 fluorescence microscope. For in vitro transfections, myocytes were isolated from untreated rats. To 10 000 rod-shaped myocytes in each well of a 12-well plate was added 1-3 Â 10 7 PFU Ad.PlbAs.GFP or 2 Â 10 7 PFU of Ad.GFP, and the cells were cultured for 48 h as described. 10 For each virus more than 90% of myocytes transfected in vitro displayed GFP.
Functional characterization
Myocytes were superfused with Krebs-Henseleit (K-H) solution (in mmol/l 119 NaCl, 2 CaCl 2 , 4.7 KCl, 0.94 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 and 11.5 glucose) gassed with 95% O 2 -5%CO 2 to pH7.4. Experiments were carried out at 371C with field stimulation at 0.5 Hz and contraction monitored by a video edge detection device (IonOptix). Contraction amplitude (% shortening with each beat) and times to peak contraction, 50 and 90% relaxation (TTP, R50, R90) were obtained under basal conditions (2 mmol/l) Ca
2+
, and then at Ca 2+ levels increasing to 4, 6 and 8 mmol/l at 3-5 min intervals. Ca 2+ transients were measured using indo-1AM at 2 mmol/l Ca 2+ and 0.5 Hz as previously described. 12 
Statistical methods
Results are shown as mean7s.e.m. Coefficient of variation is standard deviation Â 100 divided by the mean.
Comparisons of two groups were made by unpaired t-test, and of three groups by one-way ANOVA with Bonferroni post hoc test. Comparison of complete concentration-response curves was performed using the curve fitting function in Graphpad Prism v4. Differences between curves were determined by using an F-test to compare global with individual curve fits.
Results
Transfection efficiency
After o-DI, an average of 1.770.8% of the rod-shaped, viable myocytes subsequently isolated from the ventricle were identified as transfected by the presence of GFP (n ¼ 8 preparations, Figure 1 ). This was increased to 5.670.8% (n ¼ 9) by a brief immobilization of the ventricle (i-DI) during and after injection, and further to 13.271.1% (n ¼ 8) by the application of ultrasound 
Functional effect of phospholamban antisense transfection
Myocytes transfected with Ad.PlbAs.GFP showed a greater contraction amplitude at all Ca 2+ concentrations than uninfected cells from the same ventricle (Figure 2a) . Curves were significantly different by the F-test (Po0.001). Myocytes from animals transfected with the control virus, Ad.GFP, showed no such difference in contraction (Figure 2b) . However, the difference between transfected cells from Ad.PLb.As.GFP and Ad.GFP hearts was not statistically significant, largely because baseline, untransfected, amplitudes were higher for GFP hearts (Figure 2b ). This could be a chance difference between animals, or could be an indication that transfection with GFP has a different effect from PLb-As on untransfected myocytes from the same heart. Times-to-50% and 90% relaxation were reduced by Ad.PlbAs.GFP, and this was more evident at higher Ca 2+ concentrations where relaxation in control cells had become prolonged (Figure 3a,b) . Downregulation of phospholamban appeared to prevent the effect of high Ca 2+ to lengthen diastolic relaxation. Calcium transients from PLb-As transfected myocytes at 2 mM external Ca 2+ were modestly (15%) abbreviated compared to untransfected cells from the same hearts (Figure 4) .
The effect of phospholamban downregulation was compared directly between in vitro and in vivo transfections at 2 mM Ca 2+ ( Figure 5 ). There was a remarkable degree of agreement between the two regarding the increase in basal contraction amplitude after Ad. PlbAs.GFP transfection. As expected, the basal relaxation time was longer in myocytes cultured in vitro, but the percentage decrease in the Ad.PlbAs.GFP myocytes was similar (12% in each case).
Discussion
This study has shown that myocytes may be transfected in vivo and subsequently isolated from the heart to use for contraction studies. Using relatively simple modifications to the procedure, the number of transfected cells can be increased to around 15% of the total myocyte preparation. For contraction or electrophysiological 
Adenoviral gene transfer to ventricular myocytes
M Sato et al experiments on individual myocytes, it is relatively easy to use preparations with only 2-3% of transfected cells, since there may typically be 200-300 viable myocytes in a bath. This strategy is therefore well suited to the transfection of adult myocytes to study the functional effects of modification of protein levels. It is particularly suitable for targets that might require more than 48 h to have full effect, or which would be affected by the changes in the cell during culture. For example, the majority of the channel proteins, which control excitation and Ca 2+ entry or release, are located in the t-tubular system of the heart, which is partially lost within 48 h of culture in the adult cell. 13 Few other groups have employed the technique of transfecting in vivo and isolating myocytes, and then not explicitly for the purpose of obviating culture-induced changes. 14, 15 Transfection with an adenovirus containing sequence for a dominant-negative Kir2.1 potassium channel plus GFP, by injection into the left ventricular cavity rather than the muscle, was reported to yield a population of around 20% GFP-positive cells. 16 The mechanism by which each of the modifications described herein confers benefit remains to be established. It is likely that the application of the haemoclip works by increasing the contact time between virus and cells, and possibly by raising the pressure within the ventricle to allow greater dispersion of the virus. Both of these manoeuvres are known to improve delivery of virus by the intracoronary route. 15 The basis for the use of ultrasound to improve adenovirus or DNA delivery is the observation that therapeutic ultrasound can induce cell membrane permeabilization 17 although an effect of local warming cannot be excluded. It is known that viral gene transfer is temperature-sensitive. Ultrasound-mediated gene delivery has also been reported to be enhanced by the concurrent use of contrast medium 18 or microbubbles, 19 which are burst by the ultrasound pulse to provide extra impetus for gene transfer across cell barriers. It will be interesting to combine the use of microbubbles with the i-DI Ultrasound method and see whether further benefit can be obtained.
This study contains the first direct comparison of the same vector transfected into myocytes in vitro and in vivo. Lowering phospholamban levels would be expected to remove the inhibitory effect of this protein from the SR Ca 2+ -ATPase, and therefore increase uptake of Ca 2+ into the SR. This has been shown in a number of species to increase contraction, especially at higher stimulation frequencies, and to accelerate the removal of diastolic Ca 2+ and therefore increase the rate of relaxation. 3, 9, 10, 20, 21 Contraction amplitude was similar between freshly isolated and cultured myocytes, and the increase produced by phospholamban downregulation did not differ between the in vivo and in vitro groups. The expected slowing of relaxation was observed in the myocytes cultured in vitro, but the proportional effect of phospholamban antisense to accelerate relaxation was similar between the two methods. It might have been predicted that the effect of antisense after 7 days (as in the in vivo study) should have been greater than that seen in vitro, where phospholamban levels were reduced by 50-60% after 48 h. 9 However, it was shown in the in vitro studies that the effect of reduction of phospholamban by this amount was almost equivalent to that of a five-fold overexpression of SERCA2a. 9, 10 There may therefore be a maximum activity for SERCA2a, which cannot be exceeded, or which cannot be expressed as further changes in contractility.
In vivo direct injection of adenovirus represents a bridge between the transgenic animal and transfection of the isolated myocyte in vitro for investigation of the effects of gene transfer on contractile function. Generation of transgenic animals is a large investment in time, money and animals, and most centres are limited to the mouse as a species. Mutations with strong Adenoviral gene transfer to ventricular myocytes M Sato et al phenotypic correlates are often embryonic lethal, and milder alterations can be complicated by compensatory changes during development. On the other hand, transfection of isolated myocytes in vitro is limited in duration by culture-induced changes in function. 8 In vivo direct injection followed by myocyte isolation produces a rapid source of freshly isolated, transfected myocytes. Moreover, this technique should be applicable to a number of species, which will facilitate an improved choice of model system for some applications. Coupling this method with animal models of cardiac disease will further extend and refine the repertoire available for experimentation. The time between injection and isolation can also be extended to maximize overexpression or downregulation, or can be compressed to avoid compensatory alterations at the level of the myocyte, depending on the desired requirement.
Additionally, the transfection of a minor proportion of myocytes within the heart can, in some circumstances, be an advantage. Global transfection to restore heart function will produce reflex changes, with a possible decrease in heart failure-elevated hormones including catecholamines, ANP, BNP, angiotensin and cytokines. Investigation of mechanisms of recovery will therefore be confounded by the alterations in these transmitter levels. Transfection of a small number of myocytes within a heart with a given target can examine the effects of this protein change on cell contractility, viability and size without altering global cardiac function. When using the method described here for either purpose, it is important that the number of myocytes transfected does not, in fact, become large enough to alter whole heart contractility. Maximum transfection rates here were 15% for half the ventricle, approximating to 7.5% for the whole. For SERCA2a is has been found that 11% myocytes transfected is the threshold level for alteration of contractile function (Hajjar, personal communication). However, this threshold may well be different for each target. For example, genes producing pacemaker activity in previously quiescent myocytes might alter heart rate even at extremely low transfection efficiencies. It will be important in future to establish an upper limit for transfection levels to leave global contractility unaffected for any given target.
A further limitation is that focal transfection of some genes could precipitate arrhythmias, and thus alter global contractility indirectly. However, it might conversely be suggested that direct injection could be used to investigate explicitly and systematically the effects of heterogeneous transfection on the contractile state of the heart. It should be remembered that the failing heart is a heterogeneous cellular substrate 22 and, if the primary aetiology is ischaemic, there will be areas of reduced blood flow. Coronary perfusion is unlikely in this setting to produce a homogeneous transfection: even in normal guinea-pig hearts, a punctuate distribution of transfection was noted with this method. 5 It will be important with any putative vector/target combination to test the effect of nonhomogenous distribution of gene transfer, particularly with respect to the potential for arrhythmogenesis.
In summary, relatively simple modifications to the direct injection method allow the titration of the number of transfected myocytes, which can subsequently be isolated from the ventricle of adult rat. Transfected cells can be studied in vitro, extending the possibilities for the investigation of the function of various protein targets in the adult myocyte.
